We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-1.32%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$417M
AUM Growth
-$24.5M
Cap. Flow
-$15.1M
Cap. Flow %
-3.63%
Top 10 Hldgs %
23.16%
Holding
1,096
New
51
Increased
294
Reduced
328
Closed
50

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$7.46M
2
LIN icon
Linde
LIN
+$6.13M
3
LOGI icon
Logitech
LOGI
+$3.75M
4
KO icon
Coca-Cola
KO
+$1.49M
5
AMZN icon
Amazon
AMZN
+$990K

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$14.3M
2
IVE icon
iShares S&P 500 Value ETF
IVE
+$7.54M
3
ALC icon
Alcon
ALC
+$5.41M
4
RACE icon
Ferrari
RACE
+$5.16M
5
CNH
CNH Industrial
CNH
+$2.87M

Sector Composition

Rank Sector Weight
1 Financials 15.48%
2 Technology 15.28%
3 Consumer Discretionary 11.12%
4 Healthcare 10.96%
5 Industrials 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QRVO icon
476
Qorvo
QRVO
$7.92B
$140K 0.03%
836
-65
-7% -$12.1K
VHT icon
477
Vanguard Health Care ETF
VHT
$18.3B
$140K 0.03%
565
-260
-32% -$66.7K
BDEC icon
478
Innovator US Equity Buffer ETF December
BDEC
$216M
$139K 0.03%
4,151
– –
MSCI icon
479
MSCI
MSCI
$41.5B
$138K 0.03%
227
-106
-32% -$64.8K
TT icon
480
Trane Technologies
TT
$107B
$138K 0.03%
799
-70
-8% -$13.5K
FLXN
481
DELISTED
Flexion Therapeutics, Inc.
FLXN
$137K 0.03%
22,524
+22,271
+8,803% +$139K
SPG icon
482
Simon Property Group
SPG
$75.1B
$137K 0.03%
1,057
-371
-26% -$48.3K
TRUP icon
483
Trupanion
TRUP
$1.08B
$137K 0.03%
1,760
-290
-14% -$28.6K
CONE
484
DELISTED
CyrusOne Inc Common Stock
CONE
$136K 0.03%
1,760
+231
+15% +$17.4K
IBB icon
485
iShares Biotechnology ETF
IBB
$9.44B
$135K 0.03%
837
+60
+8% +$10.1K
RJF icon
486
Raymond James Financial
RJF
$33.3B
$135K 0.03%
1,460
+728
+99% +$65.2K
RPD icon
487
Rapid7
RPD
$643M
$134K 0.03%
1,188
– –
ATRS
488
DELISTED
Antares Pharma, Inc.
ATRS
$132K 0.03%
36,385
+2,139
+6% +$8.65K
CBAY
489
DELISTED
Cymabay Therapeutics
CBAY
$132K 0.03%
36,133
+1,919
+6% +$7.56K
HYFM icon
490
Hydrofarm Holdings
HYFM
$3.19M
$132K 0.03%
348
-67
-16% -$32.5K
NAD icon
491
Nuveen Quality Municipal Income Fund
NAD
$2.72B
$131K 0.03%
8,400
– –
ARGX icon
492
argenx
ARGX
$55.6B
$130K 0.03%
429
-79
-16% -$25K
THC icon
493
Tenet Healthcare
THC
$21B
$126K 0.03%
+1,889
New +$134K
PAYC icon
494
Paycom
PAYC
$7.05B
$124K 0.03%
250
– –
KNSA icon
495
Kiniksa Pharmaceuticals
KNSA
$4.89B
$123K 0.03%
10,773
+1,268
+13% +$16.5K
CCL icon
496
Carnival Corporation Ltd
CCL
$37.1B
$122K 0.03%
4,895
– –
RUN icon
497
Sunrun
RUN
$2.38B
$122K 0.03%
2,778
-17
-0.6% -$811
GTHX
498
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$122K 0.03%
9,087
+2,346
+35% +$38.2K
AWF
499
AllianceBernstein Global High Income Fund
AWF
$868M
$121K 0.03%
9,900
-1,000
-9% -$12.4K
XBI icon
500
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$121K 0.03%
963
+62
+7% +$7.98K
18 19
20
21 22

Similar funds

PC
Plaisance Capital Denver, Colorado $172M AUM 27.11% 1-Year Est. Return
TWMP
Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return
LPWM
Lake Point Wealth Management Rockwall, Texas $176M AUM 11.87% 1-Year Est. Return
ACM
Aquamarine Capital Management New York $170M AUM 15.49% 1-Year Est. Return
HWIS
Hancock Whitney Investment Services New Orleans, Louisiana $157M AUM
LWM
Loveless Wealth Management Billings, Montana $153M AUM 3.63% 1-Year Est. Return
EW
Emerson Wealth Bloomfield Hills, Michigan $153M AUM 16.38% 1-Year Est. Return
GDWAM
Gold Dragon Worldwide Asset Management Central, Hong Kong $151M AUM 54.24% 1-Year Est. Return

Exane Derivatives's Q3 2021 Portfolio in Review

As of Q3 2021, Exane Derivatives held 1,096 positions worth $417M, down 5.6% from $441M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Exane Derivatives withdrew a net $15.1M in Q3 2021, closing 50 positions and reducing 328 holdings. Its most notable exit was Kraft Heinz, an estimated $1.62M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Exane Derivatives opened a new position in Discovery, Inc. Series C Common Stock worth $796K.

  • Exane Derivatives's largest Q3 2021 buy was Discovery, Inc. Series C Common Stock: 32,809 shares worth $796K.
  • Exane Derivatives added most to UBS Group in Q3 2021, an estimated $7.46M increase.
  • Exane Derivatives's biggest Q3 2021 reduction was Stellantis, cutting an estimated $14.3M.
  • Exane Derivatives fully exited Kraft Heinz in Q3 2021, selling an estimated $1.62M.
  • Exane Derivatives's ten largest holdings make up 23% of its $417M portfolio in Q3 2021.
  • Exane Derivatives opened 51 new positions and closed 50 in Q3 2021.
  • Exane Derivatives's portfolio value fell 5.6% quarter-over-quarter to $417M.

Based on Exane Derivatives's 13F filing for Q3 2021, filed 26 Oct 2021.